Delivery Order SPE2DB22D2007-SPE2DB24FJ5WB
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,226.31 firm fixed-price delivery order covers the supply of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,226.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a completion date of August 16, 2024. The contract was awarded on August 15, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,656.99 and is a Firm Fixed Price Delivery Order for medical supplies, specifically the product "REYVOW 100 MG TABLET UD 8S." The contract has a completion date of February 10, 2025 and was awarded on February 7, 2025. The contract is not designated with a set-aside...
This federal contract award is a delivery order worth $1,020.98 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product, with a ceiling value of $1,549.05 and a performance period ending on May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,090.18 firm-fixed-price delivery order covers the procurement of 4563774504 - REYVOW 100 MG TABLET UD 8S, with a performance period through February 27, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,101.32, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of March 11, 2025 and is not designated as a set-aside. The contract provides for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product, to support federal government...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,729.58, is for the delivery of REYVOW 50 MG TABLET UD 8S, a pharmaceutical product. This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of REYVOW 50 MG TABLET UD 8S. The contract, valued at $2,641.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, worth up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,434.89, is for the delivery of REYVOW 100 MG TABLET UD 8S, a pharmaceutical product. The contract has an ultimate completion date of April 8, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...